Shahid beheshty university of medical sciences
Tehrān, Iran
NCT Number: NCT03726502
The purpose of this study is to compare ureteroscopy with and without use of safety guide-wire in treatment of ureteral stone
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Tehrān, Iran
While there are some retrospective studies compared ureteroscopy with and without use of safety guide-wire in treatment of ureteral stone, there is not randomized clinical trial in this regard. This study was designed to compare the efficacy and safety of ureteroscopy with and without use of safety guide-wire in treatment of ureteral stone
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ureteroscopy with use of safety guide-wire in treatment of ureteral stone
ureteroscopy without use of safety guide-wire in treatment of ureteral stone
ureteroscopy without use of safety guide-wire in treatment of ureteral stone
ureteroscopy with use of safety guide-wire in treatment of ureteral stone
Time frame: 3 months after surgery
rate of patients without any residue of stone
Time frame: at time of surgery
the time between insertion of ureteroscopy till insertion of catheter
Time frame: 3 months after surgery
grade of hydronephrosis is classified as: 0-4 grades
Time frame: at time of surgery
ureteral injury is classified as: Mucosal abrasion, Ureteral perforation, Intussusception / avulsion
Isfahan University of Medical Sciences
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04069013
Calculi, Female Urogenital Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT03888144
Calculi, Female Urogenital Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT07197385
Calculi, Female Urogenital Diseases
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT03692715
Calculi, Female Urogenital Diseases
São Paulo, Brazil
View Trial Details